Abstract
Evidence is increasing that the creatine/phosphocreatine shuttle system plays an essential role in energy homeostasis in the brain and retina to ensure proper development and function. Thus, our understanding of the mechanism of creatine supply and creatine usage in the brain and retina and of creatine supplementation in patients with creatine deficiency syndromes is an important step towards improved therapeutic strategies for brain and retinal disorders. Our recent research provides novel molecular-anatomical evidence that,(i) at the blood-brain barrier and the inner blood-retinal barrier, the creatine transporter (CRT/SLC6A8) functions as a major pathway for supplying creatine to the brain and retina, and that (ii) local creatine is preferentially synthesized in the glial cells, e.g., oligodendrocytes, astrocytes, and Müller cells, in the brain and retina. Thus, the blood-brain barrier and inner blood-retinal barrier play important roles not only in supplying energy sources (glucose and lactate), but also in supplying an energy ‘buffer’ (creatine). These findings lead to the novel insight that the creatine/phosphocreatine shuttle system is based on an intricate relationship between the blood-brain barrier, inner blood-retinal barrier, glia, and neurons (photoreceptor cells) to maintain and ensure energy homeostasis in the brain and retina
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acosta, M.L., Kalloniatis, M., and Christie, D.L., 2005, Creatine transporter localization in developing and adult retina: importance of creatine to retinal function. Am. J. Physiol. Cell Physiol. 289: C1015–C1023.
Almeida, L.S., Verhoeven, N.M., Roos, B., Valongo, C., Cardoso, M.L., Vilarinho, L., Salomons, G.S., and Jakobs, C., 2004, Creatine and guanidinoacetate: diagnostic markers for inborn errors in creatine biosynthesis and transport. Mol. Genet. Metab. 82: 214–219.
Balestrino, M., Rebaudo, R., and Lunardi, G., 1999, Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship. Brain Res. 816: 124–130.
Bélanger, M., Asashima, T., Ohtsuki, S., Yamaguchi, H., Ito, S., and Terasaki, T., 2007, Hyperammonemia induces transport of taurine and creatine and suppresses claudin-12 gene expression in brain capillary endothelial cells in vitro. Neurochem. Int. 50: 95–101.
Bianchi, M.C., Tosetti, M., Fornai, F., Alessandri, M.G., Cipriani, P., De Vito, G., and Canapicchi, R., 2000, Reversible brain creatine deficiency in two sisters with normal blood creatine level. Ann. Neurol. 47: 511–513.
Bizzi, A., Bugiani, M., Salomons, G.S., Hunneman, D.H., Moroni, I., Estienne, M., Danesi, U., Jakobs, C., and Uziel, G., 2002, X-linked creatine deficiency syndrome: a novel mutation in creatine transporter gene SLC6A8. Ann. Neurol. 52: 227–231.
Braissant, O., Henry, H., Loup, M., Eilers, B., and Bachmann, C., 2001, Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res. Mol. Brain Res. 86: 193–201.
Braissant, O., Bachmann, C., and Henry, H., 2007, Expression and function of AGAT, GAMT and CT1 in the mammalian brain. Subcell. Biochem. 46: 67–81.
Brewer, G.J., and Wallimann, T.W., 2000, Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J. Neurochem. 74: 1968–1978.
Cecil, K.M., Salomons, G.S., Ball, W.S., Jr., Wong, B., Chuck, G., Verhoeven, N.M., Jakobs, C., and DeGrauw, T.J., 2001, Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann. Neurol. 49: 401–404.
Dechent, P., Pouwels, P.J., Wilken, B., Hanefeld, F., and Frahm, J., 1999, Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am. J. Physiol. 277: R698–R704.
deGrauw, T.J., Salomons, G.S., Cecil, K.M., Chuck, G., Newmeyer, A., Schapiro, M.B., and Jakobs, C., 2002, Congenital creatine transporter deficiency. Neuropediatrics 33: 232–238.
Dringen, R., Verleysdonk, S., Hamprecht, B., Willker, W., Leibfritz, D., and Brand, A., 1998, Metabolism of glycine in primary astroglial cells: synthesis of creatine, serine, and glutathione. J. Neurochem. 70: 835–840.
Enerson, B.E., and Drewes, L.R., 2003, Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery. J. Pharm. Sci. 92: 1531–1544.
Gerhart, D.Z., Leino, R.L., and Drewes, L.R., 1999, Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina. Neuroscience 92: 367–375.
Guimbal, C., and Kilimann, M.W., 1993, A Na+ -dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. J. Biol. Chem. 268: 8418–8421.
Hall, S.W., and Kühn, H., 1986, Purification and properties of guanylate kinase from bovine retinas and rod outer segments. Eur. J. Biochem. 161: 551–556.
Hosoya, K., and Tomi, M., 2005, Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. Biol. Pharm. Bull. 28: 1–8.
Item, C.B., Stöckler-Ipsiroglu, S., Stromberger, C., Muhl, A., Alessandri, M.G., Bianchi, M.C., Tosetti, M., Fornai, F., and Cioni, G., 2001, Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am. J. Hum. Genet. 69: 1127–1133.
Kahler, S.G., and Fahey, M.C., 2003, Metabolic disorders and mental retardation. Am. J. Med. Genet. C Semin. Med. Genet. 117: 31–41.
Klivenyi, P., Ferrante, R.J., Matthews, R.T., Bogdanov, M.B., Klein, A.M., Andreassen, O.A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., and Beal, M.F., 1999, Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5: 347–350.
Lightman, S.L., Palestine, A.G., Rapoport, S.I., and Rechthand, E., 1987, Quantitative assessment of the permeability of the rat blood-retinal barrier to small water-soluble non-electrolytes. J. Physiol. 389: 483–490.
Magistretti, P.J., 2006, Neuron-glia metabolic coupling and plasticity. J. Exp. Biol. 209: 2304–2311.
Marescau, B., De Deyn, P., Wiechert, P., Van Gorp, L., and Lowenthal, A., 1986, Comparative study of guanidino compounds in serum and brain of mouse, rat, rabbit, and man. J. Neurochem. 46: 717–720.
Marescau, B., Deshmukh, D.R., Kockx, M., Possemiers, I., Qureshi, I.A., Wiechert, P., and De Deyn, P.P., 1992, Guanidino compounds in serum, urine, liver, kidney, and brain of man and some ureotelic animals. Metabolism 41: 526–532.
Matthews, R.T., Ferrante, R.J., Klivenyi, P., Yang, L., Klein, A.M., Mueller, G., Kaddurah-Daouk, R., and Beal, M.F., 1999, Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp. Neurol. 157: 142–149.
Matthews, R.T., Yang, L., Jenkins, B.G., Ferrante, R.J., Rosen, B.R., Kaddurah-Daouk, R., and Beal, M.F., 1998, Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease. J. Neurosci. 18: 156–163.
Nakashima, T., Tomi, M., Katayama, K., Tachikawa, M., Watanabe, M., Terasaki, T., and Hosoya, K., 2004, Blood-to-retina transport of creatine via creatine transporter (CRT) at the rat inner blood-retinal barrier. J. Neurochem. 89: 1454–1461.
Nakashima, T., Tomi, M., Tachikawa, M., Watanabe, M., Terasaki, T., and Hosoya, K.I., 2005, Evidence for creatine biosynthesis in Müller glia. Glia 52: 47–52.
Ohtsuki, S., 2004, New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system. Biol. Pharm. Bull. 27: 1489–1496.
Ohtsuki, S., Kamiya, N., Hori, S., and Terasaki, T., 2005, Vascular endothelium-selective gene induction by Tie2 promoter/enhancer in the brain and retina of a transgenic rat. Pharm. Res. 22: 852–857.
Ohtsuki, S., Kikkawa, T., Hori, S., and Terasaki, T., 2006, Modulation and compensation of the mRNA expression of energy related transporters in the brain of glucose transporter 1-deficient mice. Biol. Pharm. Bull. 29: 1587–1591.
Ohtsuki, S., Tachikawa, M., Takanaga, H., Shimizu, H., Watanabe, M., Hosoya, K., and Terasaki, T., 2002, The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain. J. Cereb. Blood Flow Metab. 22: 1327–1335.
Pardridge, W.M., Boado, R.J., and Farrell, C.R., 1990, Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J. Biol. Chem. 265: 18035–18040.
Persky, A.M., and Brazeau, G.A., 2001, Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol. Rev. 53: 161–176.
Poitry-Yamate, C.L., Poitry, S., and Tsacopoulos, M., 1995, Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina. J. Neurosci. 15: 5179–5191.
Poo-Arguelles, P., Arias, A., Vilaseca, M.A., Ribes, A., Artuch, R., Sans-Fito, A., Moreno, A., Jakobs, C., and Salomons, G., 2006, X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism. J. Inherit. Metab. Dis. 29: 220–223.
Rauen, T., and Wiessner, M., 2000, Fine tuning of glutamate uptake and degradation in glial cells: common transcriptional regulation of GLAST1 and GS. Neurochem. Int. 37: 179–189.
Salomons, G.S., van Dooren, S.J., Verhoeven, N.M., Cecil, K.M., Ball, W.S., Degrauw, T.J., and Jakobs, C., 2001, X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am. J. Hum. Genet. 68: 1497–1500.
Saltarelli, M.D., Bauman, A.L., Moore, K.R., Bradley, C.C., and Blakely, R.D., 1996, Expression of the rat brain creatine transporter in situ and in transfected HeLa cells. Dev. Neurosci. 18: 524–534.
Sather, W.A., and Detwiler, P.B., 1987, Intracellular biochemical manipulation of phototransduction in detached rod outer segments. Proc. Natl. Acad. Sci. USA 84: 9290–9294.
Schulze, A., 2003, Creatine deficiency syndromes. Mol. Cell. Biochem. 244: 143–150.
Shefner, J.M., Cudkowicz, M.E., Schoenfeld, D., Conrad, T., Taft, J., Chilton, M., Urbinelli, L., Qureshi, M., Zhang, H., Pestronk, A., Caress, J., Donofrio, P., Sorenson, E., Bradley, W., Lomen-Hoerth, C., Pioro, E., Rezania, K., Ross, M., Pascuzzi, R., Heiman-Patterson, T., Tandan, R., Mitsumoto, H., Rothstein, J., Smith-Palmer, T., MacDonald, D., and Burke, D., 2004, A clinical trial of creatine in ALS. Neurology 63: 1656–1661.
Sipilä, I., Simell, O., and Arjomaa, P., 1980, Gyrate atrophy of the choroid and retina with hyperornithinemia. Deficient formation of guanidinoacetic acid from arginine. J. Clin. Invest. 66: 684–687.
Sipilä, I., Valle, D., and Brusilow, S., 1992, Low guanidinoacetic acid and creatine concentrations in gyrate atrophy of choroids and retina (GA). In: Guanidino Compounds in Biology and Medicine (De Deyn, P.P., Marescau, B., Stalon, V., and Qureshi, I., eds.), John Libbey Ltd, London, pp 379–383.
Sora, I., Richman, J., Santoro, G., Wei, H., Wang, Y., Vanderah, T., Horvath, R., Nguyen, M., Waite, S., Roeske, W.R., and et al., 1994, The cloning and expression of a human creatine transporter. Biochem. Biophys. Res. Commun. 204: 419–427.
Stöckler, S., Hanefeld, F., and Frahm, J., 1996, Creatine replacement therapy in guanidinoacetate methyltransferase deficiency, a novel inborn error of metabolism. Lancet 348: 789–790.
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hanicke, W., and Frahm, J., 1994, Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr. Res. 36: 409–413.
Stockler, S., Schutz, P.W., and Salomons, G.S., 2007, Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology. Subcell. Biochem. 46: 149–166.
Tachikawa, M., Fukaya, M., Terasaki, T., Ohtsuki, S., and Watanabe, M., 2004, Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur. J. Neurosci. 20: 144–160.
Takata, K., Kasahara, T., Kasahara, M., Ezaki, O., and Hirano, H., 1992, Ultracytochemical localization of the erythrocyte/HepG2-type glucose transporter (GLUT1) in cells of the blood-retinal barrier in the rat. Invest. Ophthalmol. Vis. Sci. 33: 377–383.
Terasaki, T., and Ohtsuki, S., 2005, Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology. NeuroRx 2: 63–72.
Terasaki, T., Ohtsuki, S., Hori, S., Takanaga, H., Nakashima, E., and Hosoya, K., 2003, New approaches to in vitro models of blood-brain barrier drug transport. Drug Discov. Today 8: 944–954.
Vannas-Sulonen, K., Sipila, I., Vannas, A., Simell, O., and Rapola, J., 1985, Gyrate atrophy of the choroid and retina. A five-year follow-up of creatine supplementation. Ophthalmology 92: 1719–1727.
Voat, D., and Voat, J.G., 1995, Biochemistry, 2nd edn. John Wiley & Sons, Inc, Toronto, Canada.
Wallimann, T., Wegmann, G., Moser, H., Huber, R., and Eppenberger, H.M., 1986, High content of creatine kinase in chicken retina: compartmentalized localization of creatine kinase isoenzymes in photoreceptor cells. Proc. Natl. Acad. Sci. USA 83: 3816–3819.
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., and Eppenberger, H.M., 1992, Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ’phosphocreatine circuit’ for cellular energy homeostasis. Biochem. J. 281: 21–40.
Wang, Y.E., Esbensen, P., and Bentley, D., 1998, Arginine kinase expression and localization in growth cone migration. J. Neurosci. 18: 987–998.
Wyss, M., and Kaddurah-Daouk, R., 2000, Creatine and creatinine metabolism. Physiol. Rev. 80: 1107–1213.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
Tachikawa, M., Hosoya, KI., Ohtsuki, S., Terasaki, T. (2007). A Novel Relationship Between Creatine Transport at the Blood-Brain and Blood-Retinal Barriers, Creatine Biosynthesis, And its Use for Brain and Retinal Energy Homeostasis. In: Salomons, G.S., Wyss, M. (eds) Creatine and Creatine Kinase in Health and Disease. Subcellular Biochemistry, vol 46. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-6486-9_5
Download citation
DOI: https://doi.org/10.1007/978-1-4020-6486-9_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-6485-2
Online ISBN: 978-1-4020-6486-9
eBook Packages: MedicineMedicine (R0)